UnitedHealth Group saw its stock price rise approximately 7% in premarket trading on Thursday, following a second-quarter earnings report that exceeded expectations across all metrics. The company announced an adjusted earnings per share of $6.38, significantly higher than the analyst estimate of around $4.91. This represents a remarkable beat of over $1.50 per share, highlighting the company’s strong financial trajectory.
The quarterly revenue reached $112 billion, surpassing Wall Street’s forecast of $110.8 billion, although it was slightly lower than the $111.6 billion reported in the same quarter last year. The company's medical-cost ratio improved notably to 86.7%, down from 89.4% a year earlier and better than the anticipated 88.4%. These improvements were attributed to effective benefit design changes, enhanced pricing discipline, and solid medical cost management.
Operations earnings for UnitedHealth climbed to $8 billion, compared to $5.2 billion in Q2 of the previous year, indicating a strong operational performance. Following these impressive results, UnitedHealth raised its full-year 2026 adjusted earnings guidance to a range between $19.50 and $20.00 per share, positioning the midpoint at $19.75, which exceeds the analyst consensus of $18.48 to $18.49. Previously, the lowest guidance was $18.25.
The company also revised its cash flow guidance upwards to approximately $24 billion, significantly higher than the prior target of over $18 billion. In the latest quarter, cash flows from operations amounted to $11.1 billion, demonstrating a strong ratio of 1.9 times net income. Additionally, UnitedHealth has already repurchased $4 billion of its stock and anticipates buying back at least $5 billion over the entire year.
In segment performance, UnitedHealthcare served 48.5 million consumers during the quarter, contributing revenues of $86 billion and earnings of $3.9 billion. The operating margin for this segment expanded to 4.6%, a notable increase from 2.4% in Q2 2025. Meanwhile, Optum, the health services arm, reported revenues of $65.7 billion with earnings of $4 billion, also showing a year-over-year margin expansion.
CEO Stephen Hemsley remarked that these results showcase the company’s ongoing progress in enhancing operations and improving the healthcare experience for both patients and providers. The positive performance from UnitedHealth also uplifted other players in the health insurance sector, such as Humana and Centene, which experienced premarket trading gains of 4.8% and 2.5%, respectively.
This material is for informational purposes only and does not constitute financial advice.
